Human Microbiome Market Size

  • Report ID: 4062
  • Published Date: Jun 13, 2024
  • Report Format: PDF, PPT

Human Microbiome Market Size

Human Microbiome Market size was valued at USD 345.2 Million in 2023 and is expected to exceed USD 8.87 Billion by the end of 2036, expanding at over 32.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of human microbiome is evaluated at USD 441.5 Million. The rising cases of lifestyle-related diseases such as diabetes and the increasing investment in biological drug development across the globe are expected to propel market growth. It is found that dysbiosis, or abnormalities in the microbiome, can lead to the development of several lifestyle disorders.

The rise in research activities about the impact of the microbiome on health and the development of microbiome-based goods and services is predicted to create the potential for market expansion over the estimated period. Additionally, increasing technological advancements are further believed to fuel the growth of the human microbiome market. For instance, it is now simpler and less expensive to investigate the microbiome owing to developments in DNA sequencing technology.


Human Microbiome Market Overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4062
  • Published Date: Jun 13, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing prevalence of the human microbiome in health and disease and increasing research on its major impact on human physiology, metabolic and immune functions are the major factors driving the market growth.

The market size of the human microbiome is anticipated to attain a CAGR of 25% over the forecast period, i.e., 2023-2035.

The major players in the market are Seres Therapeutics, Inc., Evelo Biosciences, Inc., Synlogic, Inc., Second Genome Inc., Synthetic Biologics, Inc., YSOPIA Bioscience, 4D pharma plc, DuPont de Nemours, Inc., BiomX Inc., Sun Genomics, Inc., Viome Life Sciences, Inc.

The probiotics segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying